Items related to Development of Osmotically Controlled Drug Delivery...
Development of Osmotically Controlled Drug Delivery System: Development and In-Vitro evaluation of Elementary Osmotic Pump (Tablet) of Etoricoxib - Softcover
Etoricoxib is non steroidal anti-inflammatory drug specifically Cyclooxygenase 2 (COX-2) enzyme inhibitor. Etoricoxib have serious side effect like gastric disturbance, gastric ulceration, gastrointestinal (GIT) bleeding. Conventional drug delivery systems do not have much control over the drug release and effective concentration of drug reach at the target site. It may lead to unsteady plasma drug level result into adverse effect due to plasma drug level crossing therapeutic window and undertherparutic response because of plasma drug level below therapeutic window. GIT side effect of Etoricoxib due to unsteady plasma drug level when administered in conventional dosage form. Development of elementary osmotic pump for etoricoxib release the drug in controlled fashion by zero order result in mentainance of constant plasma drug level for long period of time lead to diminished serious GIT side effect of etoricoxib.
"synopsis" may belong to another edition of this title.
About the Author:
Ms. Tabasubano Shekh has obtained her graduation in Pharmacy i.e. B.Pharm. Her main area of research are Novel Drug Delivery System in particular the Osmotically Controlled Drug Delivery System. She has Industrial experience in Drug Regulatory Affaires Department. She Published number of research and review papers in various journals.
"About this title" may belong to another edition of this title.
- PublisherLAP LAMBERT Academic Publishing
- Publication date2013
- ISBN 10 3659370517
- ISBN 13 9783659370519
- BindingPaperback
- Number of pages80
Buy New
Learn more about this copy
US$ 37.68
Shipping:
US$ 3.99
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
Development of Osmotically Controlled Drug Delivery System: Development and In-Vitro evaluation of Elementary Osmotic Pump (Tablet) of Etoricoxib
Published by
LAP LAMBERT Academic Publishing
(2013)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
Softcover
Quantity: 19
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020281409
Buy New
US$ 37.68
Convert currency
Stock Image
Development of Osmotically Controlled Drug Delivery System: Development and In-Vitro evaluation of Elementary Osmotic Pump (Tablet) of Etoricoxib
Published by
LAP LAMBERT Academic Publishin
(2024)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
Paperback
Quantity: 20
Seller:
Rating
Book Description Paperback. Condition: New. Brand New! This item is printed on demand. Seller Inventory # 3659370517
Buy New
US$ 44.01
Convert currency
Stock Image
Development of Osmotically Controlled Drug Delivery System
Published by
LAP Lambert Academic Publishing
(2013)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783659370519_lsuk
Buy New
US$ 42.80
Convert currency
Stock Image
Development of Osmotically Controlled Drug Delivery System
Published by
LAP Lambert Academic Publishing 2013-03
(2013)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
PF
Quantity: 10
Seller:
Rating
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9783659370519
Buy New
US$ 38.09
Convert currency
Seller Image
Development of Osmotically Controlled Drug Delivery System
Published by
LAP Lambert Academic Publishing Apr 2016
(2016)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Etoricoxib is non steroidal anti-inflammatory drug specifically Cyclooxygenase 2 (COX-2) enzyme inhibitor. Etoricoxib have serious side effect like gastric disturbance, gastric ulceration, gastrointestinal (GIT) bleeding. Conventional drug delivery systems do not have much control over the drug release and effective concentration of drug reach at the target site. It may lead to unsteady plasma drug level result into adverse effect due to plasma drug level crossing therapeutic window and undertherparutic response because of plasma drug level below therapeutic window. GIT side effect of Etoricoxib due to unsteady plasma drug level when administered in conventional dosage form. Development of elementary osmotic pump for etoricoxib release the drug in controlled fashion by zero order result in mentainance of constant plasma drug level for long period of time lead to diminished serious GIT side effect of etoricoxib. 80 pp. Englisch. Seller Inventory # 9783659370519
Buy New
US$ 39.45
Convert currency
Stock Image
Development of Osmotically Controlled Drug Delivery System Development and InVitro evaluation of Elementary Osmotic Pump Tablet of Etoricoxib
Published by
LAP LAMBERT Academic Publishing
(2013)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
PAP
Quantity: > 20
Seller:
Rating
Book Description PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659370519
Buy New
US$ 67.44
Convert currency
Seller Image
Development of Osmotically Controlled Drug Delivery System : Development and In-Vitro evaluation of Elementary Osmotic Pump (Tablet) of Etoricoxib
Published by
LAP Lambert Academic Publishing
(2013)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
Taschenbuch
Quantity: 1
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Etoricoxib is non steroidal anti-inflammatory drug specifically Cyclooxygenase 2 (COX-2) enzyme inhibitor. Etoricoxib have serious side effect like gastric disturbance, gastric ulceration, gastrointestinal (GIT) bleeding. Conventional drug delivery systems do not have much control over the drug release and effective concentration of drug reach at the target site. It may lead to unsteady plasma drug level result into adverse effect due to plasma drug level crossing therapeutic window and undertherparutic response because of plasma drug level below therapeutic window. GIT side effect of Etoricoxib due to unsteady plasma drug level when administered in conventional dosage form. Development of elementary osmotic pump for etoricoxib release the drug in controlled fashion by zero order result in mentainance of constant plasma drug level for long period of time lead to diminished serious GIT side effect of etoricoxib. Seller Inventory # 9783659370519
Buy New
US$ 39.45
Convert currency
Stock Image
Development of Osmotically Controlled Drug Delivery System Development and InVitro evaluation of Elementary Osmotic Pump Tablet of Etoricoxib
Published by
LAP LAMBERT Academic Publishing
(2013)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
PAP
Quantity: > 20
Seller:
Rating
Book Description PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659370519
Buy New
US$ 43.65
Convert currency
Seller Image
Development of Osmotically Controlled Drug Delivery System
Published by
LAP LAMBERT Academic Publishing
(2013)
ISBN 10: 3659370517
ISBN 13: 9783659370519
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Shekh TabasubanoMs. Tabasubano Shekh has obtained her graduation in Pharmacy i.e. B.Pharm. Her main area of research are Novel Drug Delivery System in particular the Osmotically Controlled Drug Delivery System. She has Industrial ex. Seller Inventory # 5151722
Buy New
US$ 34.37
Convert currency